Halozyme Therapeutics Inc (HALO) — Working Capital to Net Assets Ratio

Latest as of September 2025: 97.5%

Halozyme Therapeutics Inc (HALO) has a Working Capital to Net Assets ratio of 97.5% as of September 2025. Working capital of $491.52 Million (current assets of $1.33 Billion minus current liabilities of $837.23 Million) is measured against net assets of $503.92 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Halozyme Therapeutics Inc (HALO) balance sheet quality index to measure how much of total assets are equity-financed.

WC/NA Ratio

97.5%
Working Capital / Net Assets

Working Capital

$491.52 Million
USD

Current Assets

$1.33 Billion
USD

Current Liabilities

$837.23 Million
USD

Halozyme Therapeutics Inc Working Capital to Net Assets (2001–2024)

This chart shows how Halozyme Therapeutics Inc's Working Capital to Net Assets ratio has evolved across 24 annual periods from 2001 to 2024. As of September 2025, the ratio stands at 97.5%, reflecting working capital of $491.52 Million against net assets of $503.92 Million USD. Check how tangible is Halozyme Therapeutics Inc's equity to evaluate the tangible quality of the company's equity base.

Annual Working Capital to Net Assets for Halozyme Therapeutics Inc (2001–2024)

The table below presents the year-by-year Working Capital to Net Assets ratio for Halozyme Therapeutics Inc from 2001 to 2024, covering 24 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Halozyme Therapeutics Inc (HALO) total market value.

Year WC/NA Ratio Working Capital (USD) Net Assets Current Assets Current Liabilities Change (pp)
2024 260.1% $946.24 Million $363.82 Million $1.09 Billion $139.10 Million ▼ -496.3 pp
2023 756.4% $633.93 Million $83.81 Million $746.42 Million $112.49 Million ▲ +398.2 pp
2022 358.2% $608.22 Million $169.80 Million $739.01 Million $130.79 Million ▼ -52.6 pp
2021 410.8% $809.14 Million $196.95 Million $926.29 Million $117.15 Million ▲ +322.5 pp
2020 88.3% $133.38 Million $151.05 Million $554.76 Million $421.38 Million ▼ -410.6 pp
2019 498.9% $457.80 Million $91.77 Million $543.44 Million $85.64 Million ▲ +387.0 pp
2018 111.9% $278.49 Million $248.89 Million $427.85 Million $149.36 Million ▼ -70.0 pp
2017 181.9% $379.04 Million $208.37 Million $510.37 Million $131.33 Million ▲ +803.7 pp
2016 -621.7% $201.95 Million $-32.48 Million $256.53 Million $54.59 Million ▼ -876.0 pp
2015 254.2% $109.31 Million $43.00 Million $171.77 Million $62.46 Million ▼ -77.1 pp
2014 331.3% $136.99 Million $41.35 Million $161.32 Million $24.33 Million ▲ +680.2 pp
2013 -348.9% $69.74 Million $-19.99 Million $95.20 Million $25.45 Million ▼ -578.3 pp
2012 229.4% $112.08 Million $48.85 Million $131.03 Million $18.95 Million ▼ -198.9 pp
2011 428.3% $46.69 Million $10.90 Million $63.99 Million $17.30 Million ▲ +63.9 pp
2010 364.4% $74.16 Million $20.35 Million $89.50 Million $15.34 Million ▼ -505.4 pp
2009 869.8% $60.04 Million $6.90 Million $74.44 Million $14.40 Million ▲ +481.0 pp
2008 388.8% $59.79 Million $15.38 Million $74.01 Million $14.22 Million ▲ +229.0 pp
2007 159.8% $92.31 Million $57.77 Million $101.18 Million $8.86 Million ▼ -19.3 pp
2006 179.1% $41.34 Million $23.08 Million $45.59 Million $4.25 Million ▲ +81.3 pp
2005 97.8% $17.80 Million $18.21 Million $20.11 Million $2.30 Million ▼ -0.5 pp
2004 98.3% $14.57 Million $14.82 Million $16.15 Million $1.58 Million ▼ -1.7 pp
2003 100.0% $10.06K $10.06K $47.52K $37.45K ▲ +0.0 pp
2002 100.0% $86.81K $86.81K $97.25K $10.43K ▲ +0.0 pp
2001 100.0% $22.84K $22.84K $26.13K $3.29K
pp = percentage points